Published in
BMJ Publishing Group, Journal for ImmunoTherapy of Cancer, Suppl 1(1), p. P273, 2013
DOI: 10.1186/2051-1426-1-s1-p273
Links
- BMJ Publishing Group
- [www.immunotherapyofcancer.org] | PDF
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
Journal article published in 2013 by
Trine Z. Iversen,
Lotte Engell-Noerregaard,
Eva Ellebaek,
Rikke Andersen,
Stine K. Larsen,
Jon Bjoern,
Claus Zeyher,
Cécile Gouttefangeas,
Birte M. Thomsen,
Bente Holm,
Per Straten,
Anders Mellemgaard,
Mads H. Andersen,
Inge M. Svane
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
No abstract available.